IOSP logo

Innospec Inc. (IOSP) Cash and Cash Equivalents

Annual Cash & Cash Equivalents:

$289.20M+$85.50M(+41.97%)
December 31, 2024

Summary

  • As of today, IOSP annual cash & cash equivalents is $289.20 million, with the most recent change of +$85.50 million (+41.97%) on December 31, 2024.
  • During the last 3 years, IOSP annual cash & cash equivalents has risen by +$147.40 million (+103.95%).
  • IOSP annual cash & cash equivalents is now at all-time high.

Performance

IOSP Cash and Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIOSPbalance sheet metrics

Quarterly Cash & Cash Equivalents:

$270.80M+$4.20M(+1.58%)
September 30, 2025

Summary

  • As of today, IOSP quarterly cash & cash equivalents is $270.80 million, with the most recent change of +$4.20 million (+1.58%) on September 30, 2025.
  • Over the past year, IOSP quarterly cash & cash equivalents has dropped by -$33.00 million (-10.86%).
  • IOSP quarterly cash & cash equivalents is now -10.86% below its all-time high of $303.80 million, reached on September 30, 2024.

Performance

IOSP Quarterly Cash & Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIOSPbalance sheet metrics

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

IOSP Cash and Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+42.0%-10.9%
3Y3 Years+104.0%+169.4%
5Y5 Years+282.0%+306.6%

IOSP Cash and Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+104.0%-10.9%+169.4%
5Y5-Yearat high+282.0%-10.9%+306.6%
All-TimeAll-Timeat high+1980.6%-10.9%+1848.2%

IOSP Cash and Cash Equivalents History

DateAnnualQuarterly
Sep 2025
-
$270.80M(+1.6%)
Jun 2025
-
$266.60M(-11.1%)
Mar 2025
-
$299.80M(+3.7%)
Dec 2024
$289.20M(+42.0%)
$289.20M(-4.8%)
Sep 2024
-
$303.80M(+26.5%)
Jun 2024
-
$240.20M(-11.1%)
Mar 2024
-
$270.10M(+32.6%)
Dec 2023
$203.70M(+38.5%)
$203.70M(-1.7%)
Sep 2023
-
$207.20M(+24.9%)
Jun 2023
-
$165.90M(+12.5%)
Mar 2023
-
$147.50M(+0.3%)
Dec 2022
$147.10M(+3.7%)
$147.10M(+46.4%)
Sep 2022
-
$100.50M(+40.8%)
Jun 2022
-
$71.40M(-32.4%)
Mar 2022
-
$105.60M(-25.5%)
Dec 2021
$141.80M(+34.7%)
$141.80M(+59.0%)
Sep 2021
-
$89.20M(-5.5%)
Jun 2021
-
$94.40M(-19.3%)
Mar 2021
-
$117.00M(+11.1%)
Dec 2020
$105.30M(+39.1%)
$105.30M(+58.1%)
Sep 2020
-
$66.60M(+14.4%)
Jun 2020
-
$58.20M(-14.5%)
Mar 2020
-
$68.10M(-10.0%)
Dec 2019
$75.70M(-38.5%)
$75.70M(-31.4%)
Sep 2019
-
$110.30M(+4.0%)
Jun 2019
-
$106.10M(-14.1%)
Mar 2019
-
$123.50M(+0.3%)
Dec 2018
$123.10M(+36.5%)
$123.10M(+34.7%)
Sep 2018
-
$91.40M(+38.5%)
Jun 2018
-
$66.00M(-15.5%)
Mar 2018
-
$78.10M(-13.4%)
Dec 2017
$90.20M(-11.5%)
$90.20M(+37.7%)
Sep 2017
-
$65.50M(+34.2%)
Jun 2017
-
$48.80M(+7.5%)
Mar 2017
-
$45.40M(-55.4%)
Dec 2016
$101.90M(-28.1%)
$101.90M(-39.0%)
Sep 2016
-
$167.10M(+9.1%)
Jun 2016
-
$153.20M(+33.2%)
Mar 2016
-
$115.00M(-18.8%)
Dec 2015
$141.70M(+206.0%)
$141.70M(+6.7%)
Sep 2015
-
$132.80M(+90.3%)
Jun 2015
-
$69.80M(+35.0%)
Mar 2015
-
$51.70M(+11.7%)
Dec 2014
$46.30M(-46.7%)
$46.30M(-51.4%)
Sep 2014
-
$95.30M(-2.2%)
Jun 2014
-
$97.40M(+1.6%)
Mar 2014
-
$95.90M(+10.5%)
Dec 2013
$86.80M(+215.6%)
$86.80M(+43.9%)
Sep 2013
-
$60.30M(+2.2%)
Jun 2013
-
$59.00M(+22.4%)
Mar 2013
-
$48.20M(+75.3%)
Dec 2012
$27.50M
$27.50M(-79.4%)
DateAnnualQuarterly
Sep 2012
-
$133.60M(+20.9%)
Jun 2012
-
$110.50M(+15.1%)
Mar 2012
-
$96.00M(+18.5%)
Dec 2011
$81.00M(-27.2%)
$81.00M(-40.8%)
Sep 2011
-
$136.90M(+32.4%)
Jun 2011
-
$103.40M(+9.8%)
Mar 2011
-
$94.20M(-15.4%)
Dec 2010
$111.30M(+62.2%)
$111.30M(+9.7%)
Sep 2010
-
$101.50M(+31.8%)
Jun 2010
-
$77.00M(+14.1%)
Mar 2010
-
$67.50M(-1.6%)
Dec 2009
$68.60M(+393.5%)
$68.60M(+36.7%)
Sep 2009
-
$50.20M(+12.8%)
Jun 2009
-
$44.50M(+220.1%)
Dec 2008
$13.90M(-42.8%)
$13.90M(-8.6%)
Sep 2008
-
$15.20M(-7.3%)
Jun 2008
-
$16.40M(+16.3%)
Mar 2008
-
$14.10M(-42.0%)
Dec 2007
$24.30M(-76.2%)
$24.30M(-14.1%)
Sep 2007
-
$28.30M(-18.7%)
Jun 2007
-
$34.80M(+0.3%)
Mar 2007
-
$34.70M(-65.9%)
Dec 2006
$101.90M(+39.2%)
$101.90M(+8.2%)
Sep 2006
-
$94.20M(+38.3%)
Jun 2006
-
$68.10M(+10.0%)
Mar 2006
-
$61.90M(-15.4%)
Dec 2005
$73.20M(+119.8%)
$73.20M(+6.1%)
Sep 2005
-
$69.00M(+127.7%)
Jun 2005
-
$30.30M(-33.6%)
Mar 2005
-
$45.60M(+36.9%)
Dec 2004
$33.30M(-27.8%)
$33.30M(-15.3%)
Sep 2004
-
$39.30M(-49.8%)
Jun 2004
-
$78.30M(+69.8%)
Dec 2003
$46.10M(+72.7%)
$46.10M(+4.5%)
Sep 2003
-
$44.10M(+53.7%)
Jun 2003
-
$28.70M(-8.3%)
Mar 2003
-
$31.30M(+17.2%)
Dec 2002
$26.70M(-37.9%)
$26.70M(-13.9%)
Sep 2002
-
$31.00M(+14.8%)
Jun 2002
-
$27.00M(+6.3%)
Mar 2002
-
$25.40M(-40.9%)
Dec 2001
$43.00M(-21.7%)
$43.00M(-1.8%)
Sep 2001
-
$43.80M(+40.8%)
Jun 2001
-
$31.10M(-52.9%)
Mar 2001
-
$66.00M(+59.4%)
Sep 2000
-
$41.40M(-27.4%)
Jun 2000
-
$57.00M(+256.3%)
Jun 1999
-
$16.00M(-48.9%)
Mar 1999
-
$31.30M(-36.9%)
Sep 1998
-
$49.60M(+18.1%)
Jun 1998
-
$42.00M(+26.1%)
Mar 1998
-
$33.30M
Dec 1996
$54.90M
-

FAQ

  • What is Innospec Inc. annual cash & cash equivalents?
  • What is the all-time high annual cash & cash equivalents for Innospec Inc.?
  • What is Innospec Inc. annual cash & cash equivalents year-on-year change?
  • What is Innospec Inc. quarterly cash & cash equivalents?
  • What is the all-time high quarterly cash & cash equivalents for Innospec Inc.?
  • What is Innospec Inc. quarterly cash & cash equivalents year-on-year change?

What is Innospec Inc. annual cash & cash equivalents?

The current annual cash & cash equivalents of IOSP is $289.20M

What is the all-time high annual cash & cash equivalents for Innospec Inc.?

Innospec Inc. all-time high annual cash & cash equivalents is $289.20M

What is Innospec Inc. annual cash & cash equivalents year-on-year change?

Over the past year, IOSP annual cash & cash equivalents has changed by +$85.50M (+41.97%)

What is Innospec Inc. quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of IOSP is $270.80M

What is the all-time high quarterly cash & cash equivalents for Innospec Inc.?

Innospec Inc. all-time high quarterly cash & cash equivalents is $303.80M

What is Innospec Inc. quarterly cash & cash equivalents year-on-year change?

Over the past year, IOSP quarterly cash & cash equivalents has changed by -$33.00M (-10.86%)
On this page